| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 2.1 | 0.7 | 3.0 |
| Other income | 0.3 | 0.4 | 0.5 |
| Total income | 2.4 | 1.1 | 3.5 |
| Profit before exceptional items & tax | -0.1 | 0.3 | -0.9 |
| Profit before tax | -0.1 | 0.3 | -0.9 |
| Net profit | -0.1 | 0.3 | -0.9 |
| Operating margin | -4.2% | 27.3% | -25.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -30.00% |
|---|
BSE results filing, NSE: SHREEGANES. Figures extracted from the filing.
Shree Ganesh Bio-Tech (India) Ltd: key numbers
- Share price
- ₹0.47
- Market cap
- ₹18.74 Cr
- Revenue (annual)
- ₹4.97 Cr
- Net profit (annual)
- ₹0.38 Cr
- P/E (TTM)
- -48.5×Sector 50.4×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 1.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Ganesh Bio-Tech (India) Ltd
All →Shree Ganesh Bio-Tech (India) Annual Report
Shree Ganesh Bio-Tech (India) Limited has released its Annual Report for the financial year 2025-26. The 16th Annual General Meeting is scheduled for September 28, 2026.
Shree Ganesh Bio-Tech (India) Annual General Meeting
Shree Ganesh Bio-Tech (India) Limited has issued a notice for its 16th Annual General Meeting. The meeting is scheduled for September 28, 2026, at the registered office.
Shree Ganesh Bio-Tech (India) Q1 FY27 Results: Net Loss of ₹0.6 Cr
Shree Ganesh Bio-Tech (India) Ltd reported revenue from operations of ₹1.4 Cr (+0.0% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.6 Cr